Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 7890-7897

  Ohno, Tatsukuni ^a   Oboki, Keisuke ^a   Kajiwara, Naoki ^a,d   Morii, Eiichi ^b   Aozasa, Katsuyuki ^b   Flavell, Richard A ^c   Okumura, Ko ^d   Saito, Hirohisa ^a,d   Nakae, Susumu ^a,d,e  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JUNTENDO UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPASTATIN; CASPASE 8; CASPASE 8 INHIBITOR; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 33; LIPOPOLYSACCHARIDE; AUTACOID; INTERLEUKIN 33, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-33, MOUSE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; MAST CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CYTOLOGY; DENDRITIC CELL; ENZYMOLOGY; HYPERSENSITIVITY; IMMUNOLOGY; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SECRETION; SPLEEN;

ANIMALS; BONE MARROW CELLS; CALPAIN; CASPASE 1; CASPASE 8; CELLS, CULTURED; DENDRITIC CELLS; HYPERSENSITIVITY; INFLAMMATION MEDIATORS; INTERLEUKINS; MACROPHAGES, PERITONEAL; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; SPLEEN;

EID: 76249084409     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802449     Document Type: Article

References (27)

1. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
2. Onda, H., H. Kasuya, K. Takakura, T. Hori, T. Imaizumi, T. Takeuchi, I. Inoue, and J. Takeda. 1999. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 19: 1279-1288.
3. Baekkevold, E. S., M. Roussigne, T. Yamanaka, F. E. Johansen, F. L. Jahnsen, F. Amalric, P. Brandtzaeg, M. Erard, G. Haraldsen, and J. P. Girard. 2003. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am. J. Pathol. 163: 69-79.
4. Trajkovic, V., M. J. Sweet, and D. Xu. 2004. T1/ST2: an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev. 15: 87-95.
5. Lohning, M., A. Stroehmann, A. J. Coyle, J. L. Grogan, S. Lin, J. C. Gutierrez-Ramos, D. Levinson, A. Radbruch, and T. Kamradt. 1998. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc. Natl. Acad. Sci. USA 95: 6930-6935.
6. Moritz, D. R., H. R. Rodewald, J. Gheyselinck, and R. Klemenz. 1998. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J. Immunol. 161: 4866-4874.
7. Iikura, M., H. Suto, N. Kajiwara, K. Oboki, T. Ohno, Y. Okayama, H. Saito, S. J. Galli, and S. Nakae. 2007. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest. 87: 971-978.
8. Allakhverdi, Z., D. E. Smith, M. R. Comeau, and G. Delespesse. 2007. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 179: 2051-2054.
9. Chackerian, A. A., E. R. Oldham, E. E. Murphy, J. Schmitz, S. Pflanz, and R. A. Kastelein. 2007. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 179: 2551-2555.
10. Komai-Koma, M., D. Xu, Y. Li, A. N. McKenzie, I. B. McInnes, and F. Y. Liew. 2007. IL-33 is a chemoattractant for human Th2 cells. Eur. J. Immunol. 37: 2779-2786.
11. Ho, L. H., T. Ohno, K. Oboki, N. Kajiwara, H. Suto, M. Iikura, Y. Okayama, S. Akira, H. Saito, S. J. Galli, and S. Nakae. 2007. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcεRI signals. J. Leukocyte Biol. 82: 1481-1490.
12. Humphreys, N. E., D. Xu, M. R. Hepworth, F. Y. Liew, and R. K. Grencis. 2008. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J. Immunol. 180: 2443-2449.
13. Hayakawa, H., M. Hayakawa, A. Kume, and S. Tominaga. 2007. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J. Biol. Chem. 282: 26369-26380.
14. Miller, A. M., D. Xu, D. L. Asquith, L. Denby, Y. Li, N. Sattar, A. H. Baker, I. B. McInnes, and F. Y. Liew. 2008. IL-33 reduces the development of atherosclerosis. J. Exp. Med. 205: 339-346.
15. Dinarello, C. A. 1998. Interleukin-1b, interleukin-18, and the interleukin-1b converting enzyme. Ann. NY Acad. Sci. 856: 1-11.
16. Arend, W. P., G. Palmer, and C. Gabay. 2008. IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 223: 20-38.
17. Dinarello, C. A. 1997. Interleukin-1. Cytokine Growth Factor Rev. 8: 253-265.
18. Maelfait, J., E. Vercammen, S. Janssens, P. Schotte, M. Haegman, S. Magez, and R. Beyaert. 2008. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1β maturation by caspase-8. J. Exp. Med. 205: 1967-1973.
19. Carriere, V., L. Roussel, N. Ortega, D. A. Lacorre, L. Americh, L. Aguilar, G. Bouche, and J. P. Girard. 2007. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 104: 282-287.
20. Kuida, K., J. A. Lippke, G. Ku, M. W. Harding, D. J. Livingston, M. S. Su, and R. A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267: 2000-2003.
21. Eisenbarth, S. C., D. A. Piggott, J. W. Huleatt, I. Visintin, C. A. Herrick, and K. Bottomly. 2002. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196: 1645-1651.
22. Kawakami, T., and J. Kitaura. 2005. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J. Immunol. 175: 4167-4173.
23. Talabot-Ayer, D., C. Lamacchia, C. Gabay, and G. Palmer. 2009. Interleukin-33 is biologically active independently of caspase-1 cleavage. J. Biol. Chem. 284: 19420-19426.
24. Cayrol, C., and J. P. Girard. 2009. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc. Natl. Acad. Sci. USA 106: 9021-9026.
25. Luthi, A. U., S. P. Cullen, E. A. McNeela, P. J. Duriez, I. S. Afonina, C. Sheridan, G. Brumatti, R. C. Taylor, K. Kersse, P. Vandenabeele, et al. 2009. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31: 84-98.
26. Tsutsui, H., N. Kayagaki, K. Kuida, H. Nakano, N. Hayashi, K. Takeda, K. Matsui, S. Kashiwamura, T. Hada, S. Akira, et al. 1999. Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 11: 359-367.
27. Omoto, Y., K. Tokime, K. Yamanaka, K. Habe, T. Morioka, I. Kurokawa, H. Tsutsui, K. Yamanishi, K. Nakanishi, and H. Mizutani. 2006. Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment. J. Immunol. 177: 8315-8319.